You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JTE-051

Showing 1 - 24 of 24
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Plaque Psoriasis, Skin Diseases Trial in Canada, United States (JTE-051, Placebo)

Terminated
Has Results
  • Plaque Psoriasis
  • Skin Diseases
  • JTE-051
  • Placebo
  • Fountain Valley, California
  • +15 more
Jul 15, 2021

Rheumatoid Arthritis Trial in Worldwide (JTE-051, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • JTE-051
  • Placebo
  • Tucson, Arizona
  • +38 more
Jun 11, 2021

Healthy Trial in Seoul (CKR-051 Dose 1, CKR-051 Dose 2, CKR-051 Dose 3)

Not yet recruiting
  • Healthy
  • CKR-051 Dose 1
  • +4 more
  • (no location specified)
Apr 18, 2023

Influenza Prophylaxis Trial in London (INNA-051, Placebo)

Recruiting
  • Influenza Prophylaxis
  • London, United Kingdom
    hVIVO
Apr 7, 2022

COVID-19 Pandemic Trial (INNA-051, Placebo)

Withdrawn
  • COVID-19 Pandemic
  • (no location specified)
Apr 7, 2022

Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis Trial in Worldwide (AMB-05X)

Active, not recruiting
  • Tenosynovial Giant Cell Tumor
  • Pigmented Villonodular Synovitis
  • AMB-05X
  • Columbus, Ohio
  • +5 more
Oct 5, 2022

Melanoma, Lymphoma, Solid Tumor Trial in Worldwide (Pembrolizumab)

Recruiting
  • Melanoma
  • +4 more
  • Pembrolizumab
  • Aurora, Colorado
  • +18 more
Jan 5, 2023

Plaque Psoriasis, Psoriasis, Skin Diseases Trial in Canada, Poland, United States (JTE-451 Tablets, Placebo Tablets)

Completed
Has Results
  • Plaque Psoriasis
  • +2 more
  • JTE-451 Tablets
  • Placebo Tablets
  • Santa Monica, California
  • +32 more
Aug 18, 2021

Pigmented Villonodular Synovitis, TGCT, Tenosynovial Giant Cell Tumor Trial (AMB-05X)

Not yet recruiting
  • Pigmented Villonodular Synovitis
  • +2 more
  • AMB-05X
  • (no location specified)
Apr 22, 2022

NSCLC (NSCLC), Renal Cell Carcinoma (RCC), Malignant Melanoma (MEL) Trial in Russian Federation (GNR-051)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), Malignant Melanoma (MEL)
  • GNR-051
  • Kazan, Russian Federation
  • +11 more
Sep 21, 2021

Osteoporosis, Postmenopausal Trial (MK0217, alendronate sodium / Duration of Treatment : 5 Years, Comparator : (unspecified)

Completed
  • Osteoporosis, Postmenopausal
  • MK0217, alendronate sodium / Duration of Treatment : 5 Years
  • Comparator : placebo (unspecified) /Duration of Treatment : 5 Years
  • (no location specified)
Feb 1, 2022

HIV-1 Infection Trial (ART, DOR/ISL)

Not yet recruiting
  • HIV-1 Infection
  • (no location specified)
Jan 4, 2023

Prostatic Tumors, Prostatic Cancer Trial run by the NCI (ETBX-071; adenoviral PSA vaccine, ETBX-061; adenoviral MUC1 vaccine,

Completed
Has Results
  • Prostatic Neoplasms
  • Prostatic Cancer
  • ETBX-071; adenoviral PSA vaccine
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 28, 2021

Surgery--Complications, Molar, Third Trial in Barcelona (dietary supplement, other, procedure, drug)

Completed
  • Surgery--Complications
  • Molar, Third
  • Probiotic AB-DENTALAC
  • +3 more
  • Barcelona, Spain
    Hospital de Nens de Barcelona (Children's Hospital of Barcelona)
May 5, 2020

Tumors, Prostate Cancer, Lung Cancer Trial run by the NCI (ETBX-051; adenoviral brachyury vaccine, ETBX-061; adenoviral Mucin-1

Completed
Has Results
  • Neoplasms
  • +4 more
  • ETBX-051; adenoviral brachyury vaccine
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 25, 2020

Renal Impairment Trial (Doravirine)

Completed
Has Results
  • Renal Impairment
  • (no location specified)
Sep 26, 2018

Plaque Psoriasis, Psoriasis, Skin Diseases Trial in Canada (JTE-451, Placebo)

Completed
  • Plaque Psoriasis
  • +2 more
  • Surrey, British Columbia, Canada
  • +4 more
Jun 29, 2017

Herpes Zoster Trial (ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Subcutaneous, ZOSTAVAX™ (Zoster Vaccine Live) 1/3 Dose

Completed
Has Results
  • Herpes Zoster
  • ZOSTAVAX™ (Zoster Vaccine Live) Full Dose Subcutaneous
  • +5 more
  • (no location specified)
May 19, 2016

Lymphoma, Non-Hodgkin Trial (Iodine-131 Anti-B1 Antibody Versus Anti-B1 Antibody in Chemotherapy-Relapsed/Refractory Low-Grade

Completed
Has Results
  • Lymphoma, Non-Hodgkin
  • Iodine-131 Anti-B1 Antibody Versus Anti-B1 Antibody in Chemotherapy-Relapsed/Refractory Low-Grade or Transformed Low-Grade Non-Hodgkin's Lymphoma (NHL)
  • (no location specified)
Nov 30, 2016

Cardioversion of Atrial Fibrillation (MK-6621-051)

Completed
Has Results
  • Atrial Fibrillation
    • (no location specified)
    Oct 30, 2015

    Head Neck Cancer Trial in Seoul (GX-051)

    Unknown status
    • Head and Neck Cancer
    • GX-051
    • Seoul, Korea, Republic of
      Seoul St.Mary's Hospital of the Catholic University of Korea
    Apr 29, 2015

    Ureteral Obstruction Trial in France (Insertion of Memokath 051)

    Completed
    • Ureteral Obstruction
    • Insertion of Memokath 051
    • Bordeaux, France
    • +3 more
    Aug 20, 2014

    Ureteral Obstruction Trial in Rochester (Memokath 051 Ureteral Stent, JJ Stent)

    Completed
    Has Results
    • Ureteral Obstruction
    • Memokath 051 Ureteral Stent
    • JJ Stent
    • Rochester, Minnesota
      Mayo Clinic
    Jun 19, 2014

    Asthma, Allergy Trial in Maastricht (Plant stanol enriched soy-based yoghurt, Soy-based yoghurt without added plant stanols)

    Completed
    • Asthma
    • Allergy
    • Plant stanol enriched soy-based yoghurt
    • Soy-based yoghurt without added plant stanols
    • Maastricht, Limburg, Netherlands
      Maastricht University Medical Centre
    Jan 9, 2014